💥 Borderlands 4 drops two big DLCs on Sept 10

2K announced that two new Borderlands 4 DLCs will launch simultaneously on September 10, alongside a major update increasing the level cap. 'Story Pack 2: FL4K and the Last Resort' introduces new mechanics on Providence, while 'Bounty Pack 5: Amara and the Vile Shadows' focuses on saving Kairos and Elpis. Players can unlock new gear and cosmetic items by completing missions in both packs. Additionally, the 'Version 1.10 Free Title Update' raises the character level cap by 10 levels for everyone. Borderlands 4 remains available on PlayStation 5, Xbox Series X|S, PC Steam, and Epic Games Store.

🩺 Brain death clarity: New guidelines drop 🧠

New National Guidelines on Brainstem Death Certification have been released to bring uniformity to the process. This update applies across India, clarifying that brainstem death signifies death regardless of organ donation. The guidelines were published on August 24, 2026, to reduce ambiguity for families and doctors. This change allows doctors to declare death based on irreversible brainstem destruction, rather than waiting for the heart to stop. It aims to facilitate timely organ donation for patients awaiting transplants.

💣 Southern Thailand hit by bombings and arson spree

A wave of attacks, including bombings and arson, hit southern Thailand's three border provinces starting Saturday evening, August 22, 2026. The incidents took place across Yala, Narathiwat, and Pattani districts. Preliminary reports tallied 34 incidents as of 9:42 pm, categorized into arson, bombings, shots fired, and property damage. Attacks primarily targeted public utilities and government property across the affected areas. Security forces have increased surveillance while investigators continue to examine the sites for further details. 💣

🧐 Trump's Kim strategy shakes US trust in Asia

Donald Trump's engagement with Kim Jong Un has increased global skepticism about US reliability in Asia. This diplomatic approach has raised concerns among allies across the region. Specifically, doubts have deepened as the geopolitical climate remains tense. The strategy tests US commitment amid significant regional security challenges. Future moves by the US administration will heavily influence Asian partnerships. 🧐

🏑 India's hockey semi-final hopes hang by a thread

India's Men's Hockey World Cup semi-final hopes were shaky after a 1-3 loss, but Argentina's 3-1 win over England kept the dream alive. The race for the last-four spot is now down to the final day of Group E matches on August 24. India must win against Argentina, ideally by two goals, to stay competitive. Additionally, the Netherlands needs to beat England in their final match for India to have a chance. This final day sets up a complex goal difference scenario for the top spots. 🤞

🎬 Suriya's 'Vishwanath and Sons' hits 100 Cr net

Suriya and Mamitha Baiju's 'Vishwanath and Sons' crossed the ₹100 crore mark in India net collections on its 10th day. The film was screened across 4,391 shows, collecting an estimated ₹7.30 crore on Day 10. This success comes as Lokesh Kanagaraj's 'DC' recorded a decline in earnings on its third Sunday. 'Vishwanath and Sons' currently has a total India net collection of ₹100.65 crore, while 'DC' stands at ₹65.62 crore. The film is showing steady growth while 'DC' is seeing a drop in earnings.

🗳️ Karnataka electoral rolls to lose over 1 crore voters

The draft electoral rolls in Karnataka will be published on August 24th after the Special Intensive Revision phase. This revision is expected to exclude more than 1.07 crore voters from the current electorate. Specifically, Bengaluru’s voter count will drop from over 1.03 crore to just 56.11 lakh. The public notice and objection period runs from August 24 to October 22, with final rolls by October 27. Voters with discrepancies will receive notices for hearings during this time. 🗳️

🥂 Onam sales boost: Liquor consumption expected to spike

Liquor sales are predicted to surge during the upcoming Onam festival in Kerala. The Kerala State Beverages Corporation (Bevco) is stocking up across its 289 outlets for the peak season. Last Onam, sales hit ₹970.74 crore, up from ₹842.07 crore the prior year. This trend shows a shifting social behavior where alcohol is becoming a key part of celebrations. Authorities are simultaneously ramping up drives against illicit liquor and drunk driving. 🍻

📈 Stock Market Update for Monday Trade 📊

GIFT Nifty opened 0.2% higher at 24,320, despite last week's downturn in Nifty 50 and Sensex. Asian markets were mixed as investors watched US plans regarding Iran sanctions. Crude oil prices dropped, with Brent Crude trading 2% lower at $92.60 per barrel. Indian benchmarks saw declines for the second straight week in the market recap. Traders await further details from US Treasury Secretary Scott Bessent's upcoming press conference.

📊 Market update: Big company news drops

Indian equity markets finished a choppy session on Friday, August 21, with the NSE Nifty50 closing at 24,252, up 0.08%. Reliance Industries' shareholders approved resolutions on August 20, while Bank of Baroda finalized a $400 million note issuance. Power Grid Corporation of India won a TBCB bid for a Gujarat renewable energy project at ₹822.91 crore per annum. NATCO Pharma received a Form 483 from the US FDA following an inspection between August 17 and August 21, 2026. Analysts anticipate the market will remain sideways to mildly positive in the near term. 📈

🔬 Indian labs are cracking cancer care codes

Indian research institutes have launched two major studies tackling cancer's biggest hurdles. One study, led by Dr Shubhasis Haldar at SN Bose National Centre for Basic Sciences and Ashoka University, introduces an AI framework called ACSCeND to find cancer stem-like cells. This AI analyzes over 25,000 tumour samples to predict poor survival linked to pluripotent-like cells. Parallelly, researchers at IASST-Guwahati and IIT-Guwahati developed RK-251, a small molecule that only activates within malignant cells. This targeted approach promises to reduce the severe side effects of current chemotherapy treatments.